CAMILLE WISE: Open Payments
NPI 1013949213 · HOMER, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 22 payments from 10 companies in 2025. Trend: 2023 $325 · 2024 $252 · 2025 $496
Food & beverage: $451Education: $45
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $161 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $77 |
| Lilly USA, LLC | 2 | $60 |
| Astellas Pharma US Inc | 2 | $38 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| PFIZER INC. | 2 | $32 |
| Axsome Therapeutics, Inc. | 2 | $31 |
| SHIELD THERAPEUTICS INC | 2 | $28 |
| Novartis Pharmaceuticals Corporation | 1 | $20 |
| Exact Sciences Corporation | 1 | $14 |
Products named: BREZTRI, Kerendia, FARXIGA, Veozah, GEMTESA, NURTEC ODT, Auvelity, ACCRUFER.
Industry payments across LA — which companies pay providers there.
